PCFANNI Stock Latest News
Private CompaniesGoldenrod Therapeutics Expands Visibility in Neuroinflammation Research4d agoFANNI
Private CompaniesFannin Adds Drug Development Intern to Support Neuroscience and Raptamer Programs2w agoFANNI
Private CompaniesFannin Partners Highlights Health Literacy Efforts in Clinical Trials3w agoFANNI
Private CompaniesFannin Partners Expands Operations With New Houston Office4w agoFANNI
Private CompaniesAcademic Engagement Strengthens Fannin Partners’ Innovation Pipeline1M agoFANNI
Private CompaniesAllterum Therapeutics Advances ALT-101 Phase 1 Trial in Acute Lymphoblastic Leukemia1M agoFANNIPrivate CompaniesFannin Partners Secures New Grants to Advance Raptamer-Based Therapy for Ewing Sarcoma3M agoFANNI
Private CompaniesFannin Partners – Weekly Recap3M agoFANNI
Private CompaniesFannin Portfolio Company Goldenrod Advances Neuroinflammation Program4M agoFANNI
Private CompaniesFannin Partners Emphasizes Focus on Sarcoma and Unmet Medical Needs4M agoFANNI
Private CompaniesPhase III Success for GSK B7-H3 ADC Signals Momentum in Targeted Oncology4M agoFANNI
Private CompaniesEli Lilly Acquisition Highlights Growing Investor Focus on ADC Oncology Platforms4M agoFANNIPrivate CompaniesEarly Clinical Data Underscore Potential for Off-the-Shelf CAR-T in Autoimmune Disease4M agoFANNI
Private CompaniesPhase 3 Data Underscore Potential of KRAS-Targeted Therapy in Pancreatic Cancer4M agoFANNI

